Search research articles
Contact Us
Filters
Showing results (11-20 of 138) with videos related to
Page
of 14
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)
|
January 1, 1991
Monoclonal antibody against the human peripheral lymph node homing receptor homologue (Leu 8) inhibits B cell differentiation but not B cell proliferation
Y Murakawa, W Strober, S P James
Scandinavian Journal of Rheumatology
|
March 17, 2021
Remission with tocilizumab in a patient with erosive hand osteoarthritis
M Kondo, Y Murakawa, M Honda, et al.
Pacing and Clinical Electrophysiology : PACE
|
March 1, 1990
The defibrillation success rate versus energy relationship: Part I--Curve fitting and the most efficient defibrillation energy
B E Gliner, Y Murakawa, N V Thakor
The Journal of Veterinary Medical Science
|
February 24, 2001
Unique hemagglutination activity of an isolate of Newcastle disease virus
K Takase, Y Murakawa, S Eriguchi, et al.
The American Journal of Cardiology
|
June 15, 1996
Triple atrioventricular nodal pathways can be masked
T Yamashita, Y Murakawa, K Ajiki, et al.
The American Journal of Cardiology
|
February 1, 1992
Role of sympathovagal interaction in diurnal variation of QT interval
Y Murakawa, H Inoue, A Nozaki, et al.
Journal of Cardiovascular Electrophysiology
|
October 24, 1998
Effect of atrial natriuretic peptide on electrical defibrillation efficacy
Y Murakawa, T Yamashita, Y Kanese, et al.
Pacing and Clinical Electrophysiology : PACE
|
October 30, 1998
Do the effects of antiarrhythmic drugs on defibrillation efficacy vary among different shock waveforms?
Y Murakawa, T Yamashita, Y Kanese, et al.
Journal of Cardiovascular Electrophysiology
|
August 22, 2001
His-bundle parasystole masquerading as exercise-induced 2:1 atrioventricular block
Y Kasaoka, K Ajiki, N Hayami, et al.
Journal of the American College of Cardiology
|
March 1, 1997
Can a class III antiarrhythmic drug improve electrical defibrillation efficacy during ventricular fibrillation?
Y Murakawa, T Yamashita, Y Kanese, et al.
Page
of 14
Search research articles
Search
Showing results (11-20 of 138) with videos related to
Sort By:
Page
of 14
Journal of Immunology (Baltimore, Md. : 1950)
|
January 1, 1991
Monoclonal antibody against the human peripheral lymph node homing receptor homologue (Leu 8) inhibits B cell differentiation but not B cell proliferation
Y Murakawa, W Strober, S P James
Scandinavian Journal of Rheumatology
|
March 17, 2021
Remission with tocilizumab in a patient with erosive hand osteoarthritis
M Kondo, Y Murakawa, M Honda, et al.
Pacing and Clinical Electrophysiology : PACE
|
March 1, 1990
The defibrillation success rate versus energy relationship: Part I--Curve fitting and the most efficient defibrillation energy
B E Gliner, Y Murakawa, N V Thakor
The Journal of Veterinary Medical Science
|
February 24, 2001
Unique hemagglutination activity of an isolate of Newcastle disease virus
K Takase, Y Murakawa, S Eriguchi, et al.
The American Journal of Cardiology
|
June 15, 1996
Triple atrioventricular nodal pathways can be masked
T Yamashita, Y Murakawa, K Ajiki, et al.
The American Journal of Cardiology
|
February 1, 1992
Role of sympathovagal interaction in diurnal variation of QT interval
Y Murakawa, H Inoue, A Nozaki, et al.
Journal of Cardiovascular Electrophysiology
|
October 24, 1998
Effect of atrial natriuretic peptide on electrical defibrillation efficacy
Y Murakawa, T Yamashita, Y Kanese, et al.
Pacing and Clinical Electrophysiology : PACE
|
October 30, 1998
Do the effects of antiarrhythmic drugs on defibrillation efficacy vary among different shock waveforms?
Y Murakawa, T Yamashita, Y Kanese, et al.
Journal of Cardiovascular Electrophysiology
|
August 22, 2001
His-bundle parasystole masquerading as exercise-induced 2:1 atrioventricular block
Y Kasaoka, K Ajiki, N Hayami, et al.
Journal of the American College of Cardiology
|
March 1, 1997
Can a class III antiarrhythmic drug improve electrical defibrillation efficacy during ventricular fibrillation?
Y Murakawa, T Yamashita, Y Kanese, et al.
Page
of 14